Novel applications of recombinant erythropoietin

Current Opinion in Pharmacology

Volumn 6, Issue 2, 2006, Pages 184-189

  Sharples, Edward J ^a   Thiemermann, Christoph ^a   Yaqoob, Magdi M ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 8; CASPASE 9; CISPLATIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ERYTHROPOIETIN RECEPTOR; GAMMA INTERFERON; HEMOPOIETIC GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 3 RECEPTOR; JANUS KINASE 2; RECOMBINANT ERYTHROPOIETIN; VASCULOTROPIN;

ACUTE KIDNEY FAILURE; ANEMIA; ANTIINFLAMMATORY ACTIVITY; BRAIN DISEASE; CELL MATURATION; CELL PROTECTION; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM DISEASE; DRUG BINDING SITE; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; DRUG RECEPTOR BINDING; ENZYME INHIBITION; ERYTHROID PRECURSOR CELL; EXPERIMENTAL DESIGN; GLOMERULUS FILTRATION RATE; HEAD AND NECK CANCER; HEART DISEASE; HEART HYPERTROPHY; HEART INFARCTION; HEART PROTECTION; HUMAN; KIDNEY DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; VASCULARIZATION;

ANIMALS; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN, RECOMBINANT; HUMANS; MYOCARDIAL INFARCTION;

EID: 33644846477     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2006.01.003     Document Type: Review

References (56)

1. C. Lacombe P. Mayeux Biology of erythropoietin Haematologica 83 1998 724-732
2. P.H. Maxwell M.K. Osmond C.W. Pugh A. Heryet L.G. Nicholls C.C. Tan B.G. Doe D.J. Ferguson M.H. Johnson P.J. Ratcliffe Identification of the renal erythropoietin-producing cells using transgenic mice Kidney Int 44 1993 1149-1162
3. P. Maxwell HIF-1: An oxygen response system with special relevance to the kidney J Am Soc Nephrol 14 2003 2712-2722
4. P. Jaakkola D.R. Mole Y.M. Tian M.I. Wilson J. Gielbert S.J. Gaskell Kriegsheim Av H.F. Hebestreit M. Mukherji C.J. Schofield et. al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation Science 292 2001 468-472
5. 2 homeostasis by hypoxia-inducible factor1 alpha Genes Dev 12 1998 149-162
6. C. James V. Ugo J.P. Le Couedic J. Staerk F. Delhommeau C. Lacout L. Garcon H. Raslova R. Berger A. Bennaceur-Griscelli et. al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera Nature 434 2005 1144-1148
7. C.G. Winearls D.O. Oliver M.J. Pippard C. Reid M.R. Downing P.M. Cotes Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis Lancet 2 1986 1175-1178
8. J.P. Garton M.A. Gertz T.E. Witzig P.R. Greipp J.A. Lust G. Schroeder R.A. Kyle Epoetin alfa for the treatment of the anemia of multiple myeloma. A prospective, randomized, placebo-controlled, double-blind trial Arch Intern Med 155 1995 2069-2074
9. A. Anagnostou E.S. Lee N. Kessimian R. Levinson M. Steiner Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells Proc Natl Acad Sci USA 87 1990 5978-5982
10. M. Digicaylioglu S. Bichet H.H. Marti R.H. Wenger L.A. Rivas C. Bauer M. Gassmann Localization of specific erythropoietin binding sites in defined areas of the mouse brain Proc Natl Acad Sci USA 92 1995 3717-3720
11. S.E. Juul A.T. Yachnis R.D. Christensen Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus Early Hum Dev 52 1998 235-249
12. M. Sakanaka T.C. Wen S. Matsuda S. Masuda E. Morishita M. Nagao R. Sasaki In vivo evidence that erythropoietin protects neurons from ischemic damage Proc Natl Acad Sci USA 95 1998 4635-4640
13. M. Bernaudin H.H. Marti S. Roussel D. Divoux A. Nouvelot E.T. MacKenzie E. Petit A potential role for erythropoietin in focal permanent cerebral ischemia in mice J Cereb Blood Flow Metab 19 1999 643-651
14. M. Digicaylioglu S.A. Lipton Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades Nature 412 2001 641-647
15. M.L. Brines P. Ghezzi S. Keenan D. Agnello N.C. de Lanerolle C. Cerami L.M. Itri A. Cerami Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury Proc Natl Acad Sci USA 97 2000 10526-10531
16. M. Celik N. Gokmen S. Erbayraktar M. Akhisaroglu S. Konakc C. Ulukus S. Genc K. Genc E. Sagiroglu A. Cerami M. Brines Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury Proc Natl Acad Sci USA 99 2002 2258-2263
17. A.K. Junk A. Mammis S.I. Savitz M. Singh S. Roth S. Malhotra P.S. Rosenbaum A. Cerami M. Brines D.M. Rosenbaum Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury Proc Natl Acad Sci USA 99 2002 10659-10664
18. P. Villa P. Bigini T. Mennini D. Agnello T. Laragione A. Cagnotto B. Viviani M. Marinovich A. Cerami T.R. Coleman et. al. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis J Exp Med 198 2003 971-975
19. K. Genc S. Genc H. Baskin I. Semin Erythropoietin decreases cytotoxicity and nitric oxide formation induced by inflammatory stimuli in rat oligodendrocytes Physiol Res 2005 [Epub ahead of print]
20. C. Westenfelder D.L. Biddle R.L. Baranowski Human, rat, and mouse kidney cells express functional erythropoietin receptors Kidney Int 55 1999 808-820
21. C.W. Yang C. Li J.Y. Jung S.J. Shin B.S. Choi S.W. Lim B.K. Sun Y.S. Kim J. Kim Y.S. Chang B.K. Bang Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney FASEB J 17 2003 1754-1755
22. D.A. Vesey C. Cheung B. Pat Z. Endre G. Gobe D.W. Johnson Erythropoietin protects against ischaemic acute renal injury Nephrol Dial Transplant 19 2004 348-355
23. E.J. Sharples N. Patel P. Brown K. Stewart H. Mota-Philipe M. Sheaff J. Kieswich D. Allen S. Harwood M. Raftery et. al. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion J Am Soc Nephrol 15 2004 2115-2124
24. M. Abdelrahman E.J. Sharples M.C. McDonald M. Collin N.S. Patel M.M. Yaqoob C. Thiemermann Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia Shock 22 2004 63-69
25. N.D. Vaziri X.J. Zhou S.Y. Liao Erythropoietin enhances recovery from cisplatin-induced acute renal failure Am J Physiol 266 1994 F360-F366
26. F.H. Bahlmann K. DeGroot T. Duckert E. Niemczyk E. Bahlmann S.M. Boehm H. Haller D. Fliser Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin Kidney Int 64 2003 1648-1652
27. S.V. Brodsky T. Yamamoto T. Tada B. Kim J. Chen F. Kajiya M.S. Goligorsky Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells Am J Physiol Renal Physiol 282 2002 F1140-F1149
28. N.S. Patel E.J. Sharples S. Cuzzocrea P.K. Chatterjee D. Britti M.M. Yaqoob C. Thiemermann Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo Kidney Int 66 2004 983-989
29. H. Haller K. de Groot F. Bahlmann M. Elger D. Fliser Stem cells and progenitor cells in renal disease Kidney Int 68 2005 1932-1936
30. F. Lin K. Cordes L. Li L. Hood W.G. Couser S.J. Shankland P. Igarashi Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice J Am Soc Nephrol 14 2003 1188-1199
31. M. Arriero S.V. Brodsky O. Gealekman P.A. Lucas M.S. Goligorsky Adult skeletal muscle stem cells differentiate into endothelial lineage and ameliorate renal dysfunction after acute ischemia Am J Physiol Renal Physiol 287 2004 F621-F627
32. F. Togel Z. Hu K. Weiss J. Isaac C. Lange C. Westenfelder Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms Am J Physiol Renal Physiol 289 2005 F31-F42
33. G. Stokman J.C. Leemans N. Claessen J.J. Weening S. Florquin Hematopoietic stem cell mobilization therapy accelerates recovery of renal function independent of stem cell contribution J Am Soc Nephrol 16 2005 1684-1692
34. R. Depping K. Kawakami H. Ocker J.M. Wagner M. Heringlake A. Noetzold H.H. Sievers K.F. Wagner Expression of the erythropoietin receptor in human heart J Thorac Cardiovasc Surg 130 2005 877-878
35. G.L. Wright P. Hanlon K. Amin C. Steenbergen E. Murphy M.O. Arcasoy Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury FASEB J 18 2004 1031-1033
36. C.J. Parsa A. Matsumoto J. Kim R.U. Riel L.S. Pascal G.B. Walton R.B. Thompson J.A. Petrofski B.H. Annex J.S. Stamler W.J. Koch A novel protective effect of erythropoietin in the infarcted heart J Clin Invest 112 2003 999-1007
37. L. Calvillo R. Latini J. Kajstura A. Leri P. Anversa P. Ghezzi M. Salio A. Cerami M. Brines Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling Proc Natl Acad Sci USA 100 2003 4802-4806
38. Z. Cai D.J. Manalo G. Wei E.R. Rodriguez K. Fox-Talbot H. Lu J.L. Zweier G.L. Semenza Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury Circulation 108 2003 79-85
39. A. Hirata T. Minamino H. Asanuma S. Sanada M. Fujita O. Tsukamoto M. Wakeno M. Myoishi K. Okada H. Koyama et. al. Erythropoietin just before reperfusion reduces both lethal arrhythmias and infarct size via the phosphatidylinositol-3 kinase-dependent pathway in canine hearts Cardiovasc Drugs Ther 19 2005 33-40
40. P.R. Hanlon P. Fu G.L. Wright C. Steenbergen M.O. Arcasoy E. Murphy Mechanisms of erythropoietin-mediated cardioprotection during ischemia-reperfusion injury: Role of protein kinase C and phosphatidylinositol 3-kinase signalling FASEB J 19 2005 1323-1325
41. C. Moon M. Krawczyk D. Paik E.G. Lakatta M.I. Talan Cardioprotection by recombinant human erythropoietin following acute experimental myocardial infarction: Dose response and therapeutic window Cardiovasc Drugs Ther 19 2005 243-250
42. L. Belayev L. Khoutorova W. Zhao A. Vigdorchik A. Belayev R. Busto E. Magal M.D. Ginsberg Neuroprotective effect of darbepoetin alfa, a novel recombinant erythropoietic protein, in focal cerebral ischemia in rats Stroke 36 2005 1071-1076
43. F. Fiordaliso S. Chimenti L. Staszewsky A. Bai E. Carlo I. Cuccovillo M. Doni M. Mengozzi R. Tonelli P. Ghezzi et. al. A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury Proc Natl Acad Sci USA 102 2005 2046-2051
44. S. Erbayraktar G. Grasso A. Sfacteria Q.W. Xie T. Coleman M. Kreilgaard L. Torup T. Sager Z. Erbayraktar N. Gokmen et. al. Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo Proc Natl Acad Sci USA 100 2003 6741-6746
45. M. Leist P. Ghezzi G. Grasso R. Bianchi P. Villa M. Fratelli C. Savino M. Bianchi J. Nielsen J. Gerwien et. al. Derivatives of erythropoietin that are tissue protective but not erythropoietic Science 305 2004 239-242
46. M. Brines G. Grasso F. Fiordaliso A. Sfacteria P. Ghezzi M. Fratelli R. Latini Q.W. Xie J. Smart C.J. Su-Rick et. al. Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor Proc Natl Acad Sci USA 101 2004 14907-14912
47. P.T. Jubinsky O.I. Krijanovski D.G. Nathan J. Tavernier C.A. Sieff The beta chain of the interleukin-3 receptor functionally associates with the erythropoietin receptor Blood 90 1997 1867-1873
48. Y. Hanazono K. Sasaki N. Hiroyuki Y. Yazaki H. Hirai Erythropoietin induces tyrosine phosphorylation of the βchain of the GM-CSF receptor Biochem Biophys Res Commun 208 1995 1060-1066
49. I.C. Macdougall D.E. Roberts P. Neubert A.D. Dharmasena G.A. Coles J.D. Williams Pharmacokinetics of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis Lancet 1 1989 425-427
50. P.J. Stohlawetz L. Dzirlo N. Hergovich E. Lackner C. Mensik H.G. Eichler E. Kabrna K. Geissler B. Jilma Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans Blood 95 2000 2983-2989
51. F. Scalera J.T. Kielstein J. Martens-Lobenhoffer S.C. Postel M. Tager S.M. Bode-Boger Erythropoietin increases asymmetric dimethylarginine in endothelial cells: Role of dimethylarginine dimethylaminohydrolase J Am Soc Nephrol 16 2005 892-898
52. F.H. Bahlmann R. Song S.M. Boehm M. Mengel R. von Wasielewski C. Lindschau T. Kirsch K. de Groot R. Laudeley E. Niemczyk et. al. Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure Circulation 110 2004 1006-1012
53. C. Westenfelder R.L. Baranowski Erythropoietin stimulates proliferation of human renal carcinoma cells Kidney Int 58 2000 647-657
54. L. Feldman Y. Wang J.S. Rhim N. Bhattacharya M. Loda A.J. Sytkowski Erythropoietin stimulates growth and STAT5 phosphorylation in human prostate epithelial and prostate cancer cells Prostate 66 2006 135-145
55. M. Henke R. Laszig C. Rube U. Schafer K.D. Haase B. Schilcher S. Mose K.T. Beer U. Burger C. Dougherty H. Frommhold Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial Lancet 362 2003 1255-1260
56. R.D. Lester M. Jo W.M. Campana S.L. Gonias Erythropoietin promotes MCF-7 breast cancer cell migration by an ERK/mitogen-activated protein kinase-dependent pathway and is primarily responsible for the increase in migration observed in hypoxia J Biol Chem 280 2005 39273-39277